AV, T. , Jr, Gearhart, D., WD, B. , Jr, Truan, J., Middlemore, M., Williamson, L., … Buccafusco, J. (2007). Chronic, intermittent exposure to chlorpyrifos in rats: protracted effects on axonal transport, neurotrophin receptors, cholinergic markers, and information processing. The Journal of Pharmacology and Experimental Therapeutics, 322(3), 1117-28. https://doi.org/10.1124/jpet.107.125625

AV, T. , Jr, Buccafusco, J., Jackson, W., Prendergast, M., Fontana, D., Wong, E., … Eglen, R. (1998). Enhanced delayed matching performance in younger and older macaques administered the 5-HT4 receptor agonist, RS 17017. Psychopharmacology, 135(4), 407-15. https://doi.org/10.1007/s002130050529

Prendergast, M., Jackson, W., AV, T. , Jr, Kille, N., Arneric, S., Decker, M., & Buccafusco, J. (1998). Age-related differences in distractibility and response to methylphenidate in monkeys. Cerebral Cortex (New York, N.Y. : 1991), 8(2), 164-72. https://doi.org/10.1093/cercor/8.2.164

Prendergast, M., & Buccafusco, J. (1998). (-)-Nicotine increases mRNA encoding G3PDH and the vesicular acetylcholine transporter in vivo. Neuroreport, 9(7), 1385-9. https://doi.org/10.1097/00001756-199805110-00025 (Original work published 1998)

Stone, J., AV, T. , Jr, , Prendergast, M., & Buccafusco, J. (2000). Protractive effects of chronic treatment with an acutely sub-toxic regimen of diisopropylflurophosphate on the expression of cholinergic receptor densities in rats. Brain Research, 882(1-2), 9-18. https://doi.org/10.1016/s0006-8993(00)02689-5 (Original work published 2000)

AV, T. , Jr, Stone, J., Buccafusco, J., Sickles, D., Sood, A., & Prendergast, M. (2003). Repeated exposures to subthreshold doses of chlorpyrifos in rats: hippocampal damage, impaired axonal transport, and deficits in spatial learning. The Journal of Pharmacology and Experimental Therapeutics, 305(1), 375-84. https://doi.org/10.1124/jpet.102.041897

Bain, J., Prendergast, M., AV, T. , Jr, Arneric, S., Smith, M., & Buccafusco, J. (2003). Enhanced attention in rhesus monkeys as a common factor for the cognitive effects of drugs with abuse potential. Psychopharmacology, 169(2), 150-60. https://doi.org/10.1007/s00213-003-1483-1

Gearhart, D., Sickles, D., Buccafusco, J., Prendergast, M., & AV, T. , Jr. (2007). Chlorpyrifos, chlorpyrifos-oxon, and diisopropylfluorophosphate inhibit kinesin-dependent microtubule motility. Toxicology and Applied Pharmacology, 218(1), 20-9. https://doi.org/10.1016/j.taap.2006.10.008 (Original work published 2007)

Prendergast, M., Self, R., Smith, K., Ghayoumi, L., Mullins, M., Butler, T., … AV, T. , Jr. (2007). Microtubule-associated targets in chlorpyrifos oxon hippocampal neurotoxicity. Neuroscience, 146(1), 330-9. https://doi.org/10.1016/j.neuroscience.2007.01.023 (Original work published 2007)

Buccafusco, J., Powers, J., Hernandez, M., Prendergast, M., Terry, A., & Jonnala, R. (2007). MHP-133, a drug with multiple CNS targets: potential for neuroprotection and enhanced cognition. Neurochemical Research, 32(7), 1224-37. https://doi.org/10.1007/s11064-007-9294-0